No Cover Image

Journal article 1481 views 133 downloads

Olympic Doping, Transparency, and the Therapeutic Exemption Process

Luke Cox, Andrew Bloodworth Orcid Logo, Michael McNamee Orcid Logo

Diagoras, Volume: 1, Pages: 55 - 74

Swansea University Authors: Luke Cox, Andrew Bloodworth Orcid Logo, Michael McNamee Orcid Logo

Check full text

Abstract

Within anti-doping policy, the Therapeutic Use Exemption policy enables athletes with a range of medical conditions to compete within elite sport even after receiving prohibited medication substances or methods. It has been claimed, however, that the policy is being misused as a means to enhancing p...

Full description

Published in: Diagoras
ISSN: 2565-196X
Published: 2017
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa36798
Tags: Add Tag
No Tags, Be the first to tag this record!
first_indexed 2017-11-16T20:20:00Z
last_indexed 2023-01-11T14:11:53Z
id cronfa36798
recordtype SURis
fullrecord <?xml version="1.0"?><rfc1807><datestamp>2022-11-02T13:50:09.1856489</datestamp><bib-version>v2</bib-version><id>36798</id><entry>2017-11-16</entry><title>Olympic Doping, Transparency, and the Therapeutic Exemption Process</title><swanseaauthors><author><sid>9811ac84cad867903c385bf7086dfd2d</sid><firstname>Luke</firstname><surname>Cox</surname><name>Luke Cox</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>3d3183652dd8a45724e24c671b295889</sid><ORCID>0000-0002-4601-442X</ORCID><firstname>Andrew</firstname><surname>Bloodworth</surname><name>Andrew Bloodworth</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>85b0b1623e55d977378622a6aab7ee6e</sid><ORCID>0000-0002-5857-909X</ORCID><firstname>Michael</firstname><surname>McNamee</surname><name>Michael McNamee</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2017-11-16</date><deptcode>FGSEN</deptcode><abstract>Within anti-doping policy, the Therapeutic Use Exemption policy enables athletes with a range of medical conditions to compete within elite sport even after receiving prohibited medication substances or methods. It has been claimed, however, that the policy is being misused as a means to enhancing performance in healthy athletes, or athletes who do not suffer from a relevant pathological condition. To counter misuse of TUEs, it has claimed that the data captured in the TUE process should be transparent, even though this would reveal medical information concerning the athlete that would normally be thought of as private. There are further concerns regarding the sharing of medical data within sports organisations, between medical professionals and performance directors or coaches. We critically explore the TUE process, and argue against proposals for a transparent TUE policy on grounds of privacy and concerns for athlete welfare .We conclude that the notion of sports integrity, the threat of doping, and the extension of anti-doping policy, need to be considered within a broader context that also concerns the goals of sports medicine and athlete welfare.</abstract><type>Journal Article</type><journal>Diagoras</journal><volume>1</volume><journalNumber/><paginationStart>55</paginationStart><paginationEnd>74</paginationEnd><publisher/><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint/><issnElectronic>2565-196X</issnElectronic><keywords>Doping, Ethics, Privacy, Transparency, Sports medicine, Data sharing</keywords><publishedDay>31</publishedDay><publishedMonth>10</publishedMonth><publishedYear>2017</publishedYear><publishedDate>2017-10-31</publishedDate><doi/><url>http://www.diagorasjournal.com/index.php/diagoras/article/view/8</url><notes>Full text via - http://www.diagorasjournal.com/index.php/diagoras/article/view/8</notes><college>COLLEGE NANME</college><department>Science and Engineering - Faculty</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>FGSEN</DepartmentCode><institution>Swansea University</institution><apcterm/><funders/><projectreference/><lastEdited>2022-11-02T13:50:09.1856489</lastEdited><Created>2017-11-16T13:12:44.9783519</Created><path><level id="1">Faculty of Science and Engineering</level><level id="2">School of Aerospace, Civil, Electrical, General and Mechanical Engineering - Sport and Exercise Sciences</level></path><authors><author><firstname>Luke</firstname><surname>Cox</surname><order>1</order></author><author><firstname>Andrew</firstname><surname>Bloodworth</surname><orcid>0000-0002-4601-442X</orcid><order>2</order></author><author><firstname>Michael</firstname><surname>McNamee</surname><orcid>0000-0002-5857-909X</orcid><order>3</order></author></authors><documents><document><filename>36798__25641__96808221fd1e438d83e0edb9ac272a76.pdf</filename><originalFilename>36798_VoR.pdf</originalFilename><uploaded>2022-11-02T13:48:15.8752191</uploaded><type>Output</type><contentLength>127921</contentLength><contentType>application/pdf</contentType><version>Version of Record</version><cronfaStatus>true</cronfaStatus><documentNotes>Released under the terms of a CC-BY-NC-ND license</documentNotes><copyrightCorrect>true</copyrightCorrect><language>eng</language><licence>https://creativecommons.org/licenses/by-nc-nd/4.0/</licence></document></documents><OutputDurs/></rfc1807>
spelling 2022-11-02T13:50:09.1856489 v2 36798 2017-11-16 Olympic Doping, Transparency, and the Therapeutic Exemption Process 9811ac84cad867903c385bf7086dfd2d Luke Cox Luke Cox true false 3d3183652dd8a45724e24c671b295889 0000-0002-4601-442X Andrew Bloodworth Andrew Bloodworth true false 85b0b1623e55d977378622a6aab7ee6e 0000-0002-5857-909X Michael McNamee Michael McNamee true false 2017-11-16 FGSEN Within anti-doping policy, the Therapeutic Use Exemption policy enables athletes with a range of medical conditions to compete within elite sport even after receiving prohibited medication substances or methods. It has been claimed, however, that the policy is being misused as a means to enhancing performance in healthy athletes, or athletes who do not suffer from a relevant pathological condition. To counter misuse of TUEs, it has claimed that the data captured in the TUE process should be transparent, even though this would reveal medical information concerning the athlete that would normally be thought of as private. There are further concerns regarding the sharing of medical data within sports organisations, between medical professionals and performance directors or coaches. We critically explore the TUE process, and argue against proposals for a transparent TUE policy on grounds of privacy and concerns for athlete welfare .We conclude that the notion of sports integrity, the threat of doping, and the extension of anti-doping policy, need to be considered within a broader context that also concerns the goals of sports medicine and athlete welfare. Journal Article Diagoras 1 55 74 2565-196X Doping, Ethics, Privacy, Transparency, Sports medicine, Data sharing 31 10 2017 2017-10-31 http://www.diagorasjournal.com/index.php/diagoras/article/view/8 Full text via - http://www.diagorasjournal.com/index.php/diagoras/article/view/8 COLLEGE NANME Science and Engineering - Faculty COLLEGE CODE FGSEN Swansea University 2022-11-02T13:50:09.1856489 2017-11-16T13:12:44.9783519 Faculty of Science and Engineering School of Aerospace, Civil, Electrical, General and Mechanical Engineering - Sport and Exercise Sciences Luke Cox 1 Andrew Bloodworth 0000-0002-4601-442X 2 Michael McNamee 0000-0002-5857-909X 3 36798__25641__96808221fd1e438d83e0edb9ac272a76.pdf 36798_VoR.pdf 2022-11-02T13:48:15.8752191 Output 127921 application/pdf Version of Record true Released under the terms of a CC-BY-NC-ND license true eng https://creativecommons.org/licenses/by-nc-nd/4.0/
title Olympic Doping, Transparency, and the Therapeutic Exemption Process
spellingShingle Olympic Doping, Transparency, and the Therapeutic Exemption Process
Luke Cox
Andrew Bloodworth
Michael McNamee
title_short Olympic Doping, Transparency, and the Therapeutic Exemption Process
title_full Olympic Doping, Transparency, and the Therapeutic Exemption Process
title_fullStr Olympic Doping, Transparency, and the Therapeutic Exemption Process
title_full_unstemmed Olympic Doping, Transparency, and the Therapeutic Exemption Process
title_sort Olympic Doping, Transparency, and the Therapeutic Exemption Process
author_id_str_mv 9811ac84cad867903c385bf7086dfd2d
3d3183652dd8a45724e24c671b295889
85b0b1623e55d977378622a6aab7ee6e
author_id_fullname_str_mv 9811ac84cad867903c385bf7086dfd2d_***_Luke Cox
3d3183652dd8a45724e24c671b295889_***_Andrew Bloodworth
85b0b1623e55d977378622a6aab7ee6e_***_Michael McNamee
author Luke Cox
Andrew Bloodworth
Michael McNamee
author2 Luke Cox
Andrew Bloodworth
Michael McNamee
format Journal article
container_title Diagoras
container_volume 1
container_start_page 55
publishDate 2017
institution Swansea University
issn 2565-196X
college_str Faculty of Science and Engineering
hierarchytype
hierarchy_top_id facultyofscienceandengineering
hierarchy_top_title Faculty of Science and Engineering
hierarchy_parent_id facultyofscienceandengineering
hierarchy_parent_title Faculty of Science and Engineering
department_str School of Aerospace, Civil, Electrical, General and Mechanical Engineering - Sport and Exercise Sciences{{{_:::_}}}Faculty of Science and Engineering{{{_:::_}}}School of Aerospace, Civil, Electrical, General and Mechanical Engineering - Sport and Exercise Sciences
url http://www.diagorasjournal.com/index.php/diagoras/article/view/8
document_store_str 1
active_str 0
description Within anti-doping policy, the Therapeutic Use Exemption policy enables athletes with a range of medical conditions to compete within elite sport even after receiving prohibited medication substances or methods. It has been claimed, however, that the policy is being misused as a means to enhancing performance in healthy athletes, or athletes who do not suffer from a relevant pathological condition. To counter misuse of TUEs, it has claimed that the data captured in the TUE process should be transparent, even though this would reveal medical information concerning the athlete that would normally be thought of as private. There are further concerns regarding the sharing of medical data within sports organisations, between medical professionals and performance directors or coaches. We critically explore the TUE process, and argue against proposals for a transparent TUE policy on grounds of privacy and concerns for athlete welfare .We conclude that the notion of sports integrity, the threat of doping, and the extension of anti-doping policy, need to be considered within a broader context that also concerns the goals of sports medicine and athlete welfare.
published_date 2017-10-31T03:46:08Z
_version_ 1763752195104178176
score 11.037275

Similar Items